Company Encyclopedia
View More
name
GIANT BIOGENE
02367.HK
Giant Biogene Holding Co., Ltd., an investment holding company, designs, develops, manufactures, and sells skin treatment products with recombinant collagen in the People’s Republic of China. It also develops and manufactures rare ginsenosides technology-based functional food products; and offers medical devices. The company provides its functional skincare products, medical dressings, and functional food products primarily under the Comfy, Collgene, Ke Yu, and SKIGIN brands. Giant Biogene Holding Co., Ltd.
184.27 B
02367.HKMarket value -Rank by Market Cap -/-

Financial Score

14/12/2025 Update
B
Personal Care ProductsIndustry
Industry Ranking2/20
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE29.86%A
    • Profit Margin37.00%A
    • Gross Margin81.68%A
  • Growth ScoreA
    • Revenue YoY37.26%A
    • Net Profit YoY28.09%B
    • Total Assets YoY47.75%A
    • Net Assets YoY56.65%A
  • Cash ScoreB
    • Cash Flow Margin270.25%C
    • OCF YoY37.26%A
  • Operating ScoreB
    • Turnover0.64B
  • Debt ScoreA
    • Gearing Ratio18.58%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    UBS Sticks to Its Hold Rating for Giant Biogene Holding Co. Ltd. (2367)

    UBS analyst Ingrid Zhang maintained a Hold rating for Giant Biogene Holding Co. Ltd. with a price target of HK$39.50. The stock closed at HK$36.20. Despite a general Strong Buy consensus with a HK$56.45 target, another report also reiterated a Hold rating with a HK$43.00 target.

    Tip Ranks·
    HK
    02367
    +2.15%
    Tip Ranks·
    HK
    02367
    +2.15%

    HSBC Sticks to Their Buy Rating for Giant Biogene Holding Co. Ltd. (2367)

    HSBC maintains a Buy rating for Giant Biogene Holding Co. Ltd. with a price target of HK$46.40, while Citi also keeps a Buy rating with a target of HK$44.60. The stock closed at HK$38.30, and analysts suggest a Strong Buy consensus with an average target of HK$61.95, indicating a 61.75% upside potential.

    Tip Ranks·
    HK
    02367
    +2.15%
    Tip Ranks·
    HK
    02367
    +2.15%

    HSBC Research lowers the target price for GIANT BIOGENE to 46.4 yuan, maintaining a "Buy" rating

    HSBC Research has lowered the target price for GIANT BIOGENE to 46.4 yuan, maintaining a "Buy" rating. Due to growth pressures on the Comfy brand, profit forecasts for 2025-2027 have been reduced by 17-25%. Nevertheless, the medical aesthetics business may become a positive catalyst in 2026. Previously, GIANT BIOGENE updated its full-year performance guidance during a conference call, expecting a mid to high single-digit decline in net profit for 2025, with revenue remaining flat or slightly declining

    AASTOCKS·
    HK
    02367
    +2.15%
    AASTOCKS·
    HK
    02367
    +2.15%

    Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Morgan Stanley

    Morgan Stanley analyst maintained a Buy rating on Giant Biogene Holding Co. Ltd. with a price target of HK$78.00. The company's shares closed at HK$39.70. Jefferies also issued a Buy rating, while TR reiterated a Hold rating.

    Tip Ranks·
    HK
    02367
    +2.15%
    Tip Ranks·
    HK
    02367
    +2.15%

    Bank of America Securities Keeps Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)

    Bank of America Securities and Jefferies both maintain a Buy rating for Giant Biogene Holding Co. Ltd., with price targets of HK$55.50 and HK$55.00 respectively. The stock closed at HK$39.70, and analysts suggest a Strong Buy consensus with an average price target of HK$63.71, indicating a 60.48% upside.

    Tip Ranks·
    HK
    02367
    +2.15%
    Tip Ranks·
    HK
    02367
    +2.15%
    Posts
    View More

    $MAO GEPING(01318.HK) feels like it's not that hot, will check the excess multiple later $GIANT BIOGENE(02367.HK)

    • 0
    © 2025 Longbridge｜Disclaimer